No Word From Pfizer, AstraZeneca As Deal Chatter Tapers
More than a week after regulators loosened restrictions on second-wave deal talks between Pfizer Inc. and AstraZeneca PLC, the companies appear as far as ever from the bargaining table amid rumors...To view the full article, register now.
Already a subscriber? Click here to view full article